{"output": [["Harbour BioMed", "ORG", "Appoint", "Xiaoxiang Chen", "PERSON"], ["Xiaoxiang Chen", "PERSON", "Bring", "Leadership Experience", "CONCEPT"], ["Xiaoxiang Chen", "PERSON", "Worked", "Boehringer Ingelheim", "ORG"], ["Harbour BioMed", "ORG", "Operate_In", "Clinical Development Programs", "CONCEPT"], ["Jingsong Wang", "PERSON", "Founder and CEO", "Harbour BioMed", "ORG"], ["Xiaoxiang Chen", "PERSON", "Experienced", "Clinical Development", "CONCEPT"], ["Xiaoxiang Chen", "PERSON", "Led", "Clinical Development", "CONCEPT"], ["Xiaoxiang Chen", "PERSON", "Registered", "Global Innovative Products", "CONCEPT"], ["Xiaoxiang Chen", "PERSON", "Medical Lead", "Emerging Markets", "GPE"], ["Xiaoxiang Chen", "PERSON", "Overall Medical Responsibilities", "Clinical Development", "CONCEPT"], ["Xiaoxiang Chen", "PERSON", "Served", "Boehringer Ingelheim", "ORG"], ["Xiaoxiang Chen", "PERSON", "Served", "Wyeth Asia Pacific", "ORG"], ["Xiaoxiang Chen", "PERSON", "Received", "Medical Degree", "CONCEPT"], ["Harbour BioMed", "ORG", "Discovering and Developing", "Innovative Therapeutics", "CONCEPT"], ["Harbour BioMed", "ORG", "Focus", "Immuno-oncology", "CONCEPT"], ["Harbour BioMed", "ORG", "Focus", "Immunological Diseases", "CONCEPT"], ["Harbour BioMed", "ORG", "Owns", "Harbour Antibodies", "ORG"], ["Harbour Antibodies", "ORG", "Owns", "Transgenic Mice", "CONCEPT"], ["Harbour Antibodies", "ORG", "Generate", "H2L2 Antibodies", "CONCEPT"], ["Harbour Antibodies", "ORG", "Generate", "HCAb", "CONCEPT"], ["HCAb", "CONCEPT", "Enable", "Development", "CONCEPT"], ["HCAb", "CONCEPT", "Development", "Antibody Fragment-Based Therapeutics", "CONCEPT"], ["Harbour Antibodies", "ORG", "License", "Platforms", "CONCEPT"], ["Harbour Antibodies", "ORG", "License", "Companies and Academic Institutions", "CONCEPT"]], "published": "2018-01-03T16:00:00.000+02:00"}